T. Wikberg et al., IDENTIFICATION OF MAJOR URINARY METABOLITES OF THE CATECHOL-O-METHYLTRANSFERASE INHIBITOR ENTACAPONE IN THE DOG, European journal of drug metabolism and pharmacokinetics, 18(4), 1993, pp. 359-367
Metabolites of entacapone, -cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitro
phenyl) propenamide, a potent inhibitor of catechol-O-methyltransferas
e, were isolated from dog urine. After hydrolysis of glucuronides and
sulfates, 5 metabolites were identified in addition to unchanged entac
apone by HPLC with diode-array UV detection, electron ionization mass
spectrometry and IR spectroscopy. The (Z)-isomer of entacapone was the
most abundant phase I metabolite while less abundant metabolites were
formed through cleavage or reduction of the side chain carbon-carbon
double bond, hydrolysis of the amide bond or through hydration of the
nitrile group. The most abundant urinary metabolites were glucuronides
. The glucuronidation site of these ortho-nitrocatechols was shown to
be the hydroxyl meta to the nitro group.